|
杜瓦瓶
|
W4368-B665ml-1EA
|
容量: 665ml(外部高度×宽度:240×100mm);包装: 1个 |
N/A |
1EA
|
¥ 1035.9
|
现货 |
|
0 |
阿拉丁 |
|
2-溴-3-(溴甲基)噻吩
|
W137592-1g
|
≥96% |
40032-76-6 |
1g
|
¥ 262.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三氯氧钒
|
V300852-5g
|
≥95% |
7727-18-6 |
5g
|
¥ 159.9
|
现货 |
|
0 |
阿拉丁 |
|
三氯氧钒
|
V300852-1g
|
≥95% |
7727-18-6 |
1g
|
¥ 39.9
|
现货 |
|
0 |
阿拉丁 |
|
乙烯基环己烷
|
V162939-1ml
|
≥98%(GC) |
695-12-5 |
1ml
|
¥ 109.9
|
现货 |
|
0 |
阿拉丁 |
|
TAE缓冲液
|
T301890-500ml
|
1×,无菌,DEPC处理 |
N/A |
500ml
|
¥ 329.9
|
现货 |
|
0 |
阿拉丁 |
|
TAE缓冲液
|
T301889-500ml
|
50×,无菌,DEPC处理 |
N/A |
500ml
|
¥ 477.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
TAE缓冲液
|
T301888-500ml
|
1× |
N/A |
500ml
|
¥ 171.9
|
现货 |
|
0 |
阿拉丁 |
|
胰蛋白酶-EDTA消化液
|
T301862-100ml
|
0.25%,无菌,不含酚红 |
N/A |
100ml
|
¥ 171.9
|
现货 |
|
0 |
阿拉丁 |
|
四甲基氢氧化铵溶液
|
T301823-1L
|
单个金杂≤1ppb |
75-59-2 |
1L
|
¥ 1049.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
三(2-呋喃基)膦
|
T301762-100g
|
≥98% |
5518-52-5 |
100g
|
¥ 3577.9
|
现货 |
|
0 |
阿拉丁 |
|
三(2-呋喃基)膦
|
T301762-25g
|
≥98% |
5518-52-5 |
25g
|
¥ 980.9
|
现货 |
|
0 |
阿拉丁 |
|
三(2-呋喃基)膦
|
T301762-5g
|
≥98% |
5518-52-5 |
5g
|
¥ 280.9
|
现货 |
|
0 |
阿拉丁 |
|
三(2-呋喃基)膦
|
T301762-1g
|
≥98% |
5518-52-5 |
1g
|
¥ 95.9
|
现货 |
|
0 |
阿拉丁 |
|
三(2-呋喃基)膦
|
T301762-250mg
|
≥98% |
5518-52-5 |
250mg
|
¥ 54.9
|
现货 |
|
0 |
阿拉丁 |
|
二氧化钛
|
T301758-2.5kg
|
欧洲药典, average particle size:0.1-0.3μm |
13463-67-7 |
2.5kg
|
¥ 699.9
|
现货 |
|
0 |
阿拉丁 |
|
二氧化钛
|
T301758-500g
|
欧洲药典, average particle size:0.1-0.3μm |
13463-67-7 |
500g
|
¥ 189.9
|
现货 |
|
0 |
阿拉丁 |
|
硫醇PEG胺,HS-PEG-NH2,盐酸盐
|
T301748-500mg
|
MW 2000 Da |
N/A |
500mg
|
¥ 1338.9
|
现货 |
|
0 |
阿拉丁 |
|
硫醇PEG胺,HS-PEG-NH2,盐酸盐
|
T301748-100mg
|
MW 2000 Da |
N/A |
100mg
|
¥ 816.9
|
现货 |
|
0 |
阿拉丁 |
|
TBE缓冲液
|
T301543-500ml
|
10× |
N/A |
500ml
|
¥ 338.9
|
现货 |
|
0 |
阿拉丁 |
|
TBE缓冲液
|
T301543-100ml
|
10× |
N/A |
100ml
|
¥ 81.9
|
现货 |
|
0 |
阿拉丁 |
|
硫酸亚钛溶液
|
T299732-25kg
|
15%-20%in sulfuric acid |
10343-61-0 |
25kg
|
¥ 9269.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
总酸值标准
|
T197222-50g
|
4.5mg/g KOH |
N/A |
50g
|
¥ 2544.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
总酸值标准
|
T197221-50g
|
3.0mg/g KOH |
N/A |
50g
|
¥ 2544.9
|
期货,请咨询 |
|
0 |
阿拉丁 |